v3.26.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The Company records all cash flow hedging instruments on the consolidated balance sheets at fair value. The fair values of outstanding derivative instruments designated as cash flow hedging instruments were as follows:
March 31,
December 31,
20262025
Unaudited
Prepaid expenses and other current assets636 534 
Accrued expenses and other current liabilities(849)$— 
Schedule of Derivative Instruments, Gain (Loss)
The gains (losses) related to cash flow hedging instruments, recorded in the consolidated interim statements of income (loss), for the three months ended March 31, 2026 and 2025, were as follows:
Three Months Ended
March 31,
20262025
Unaudited
Cost of revenues$49 $16 
Research and development493 148 
Sales and marketing109 38 
General and administrative87 26 
Total gains recognized in the consolidated statements of income (loss), net
$738 $228 
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
The changes in unrealized gains (losses) on the Company’s derivative instruments recorded in accumulated other comprehensive income (loss) were as follows:
Three months ended
March 31,
20262025
Unaudited
Unrealized gains on derivative instruments at the beginning of the period$534 $418 
Changes in fair value of derivative instruments(130)(963)
Reclassification of gains recognized in the consolidated interim statements of loss from accumulated other comprehensive income (loss)(738)(228)
Unrealized losses on derivative instruments at the end of the period (unaudited)$(334)$(773)